MoneyWorks4Me

Jenburkt Pharmaceuticals informs about updates

31 Dec 2018 Evaluate

Jenburkt Pharmaceuticals has informed that the company proposed to transact a Special Resolution of approval of terms of remuneration of the Chairman and Managing Director of the Company, pursuant to the amendment in the Companies Act, 2013 by way of postal ballot route, kindly find attached a soft copy of Notice and Form of Postal Ballot in this regard, in pursuance of Regulation 30 of LODR. The Postal Ballot commenced at 9.00 am on 29th December, 2018 and shall end at 5.00 pm on 28th January, 2019. The Shareholders have been provided with option to vote electronically. CDSL has been appointed as a service provider in this regard.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..